Stay updated on Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedThe pancreatic cancer clinical trial record is now available, with study design and treatment-arm details, participant criteria, outcome measures, and supporting documents.SummaryDifference59%

- Check10 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page, and the site revision advances from v3.7.1 to v3.7.2. The study record itself still displays a 403 error.SummaryDifference1%

- Check38 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, so the page displays a generic error instead of the study details. The visible changes include a 403 heading and a 'Home' link, indicating an access restriction rather than content updates.SummaryDifference20%

- Check59 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, signaling an administrative update to the study record.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.